Degradation is a gradual process, not a sudden event
EMILY MORRIS ND, MSAOM Specializes in primary care, acupuncture, and Traditional Chinese Medicine
At its July 23 and 24 meetings, the committee will consider whether the seven peptides should be added to the 503A Bulks List
Potential concerns include: Unknown product quality Contamination or sterility issues Incorrect dosing Injection site reactions Allergic or immune reactions Medication interactions Hormonal or metabolic effects Unclear long-term safety Lack of monitoring Delayed treatment for an actual injury or medical condition Medical oversight is especially important for patients with autoimmune conditions, cancer history, active infections, chronic inflammatory disorders, cardiovascular concerns, hormone-sensitive conditions, or complex medication regimens
2003;149(Pt 6):146174
Brewster GS, Wang D, McPhillips MV, Epps F, Yang I